Lower frequencies of Vβ23+ CD8+ T cells were also observed in patients at stages 1 (p = 0.000) and 3 (p < 0.001), regardless of the presence of lymphoma and in patients with lymphoma (p = 0005). The gene discussed is CD8A; the disease is lymphoma.